Cargando…

Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide

Increased podocalyxin (PODXL) expression has been associated with a subset of aggressive types of cancer. To the best of our knowledge, the effect of PODXL on astrocytoma cell invasion and survival against chemotherapy agent was investigated for the first time in the present study. Overexpression an...

Descripción completa

Detalles Bibliográficos
Autores principales:	WU, HAO, YANG, LIANG, LIAO, DAGUANG, CHEN, YUDAN, WANG, WEI, FANG, JIASHENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627468/ https://www.ncbi.nlm.nih.gov/pubmed/23596468 http://dx.doi.org/10.3892/etm.2013.957

Ejemplares similares

Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence
por: HUANG, TIANXIANG, et al.
Publicado: (2013)

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
por: Fujimaki, Takamitsu, et al.
Publicado: (2007)

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas
por: Omar, Ayman I, et al.
Publicado: (2010)

Podocalyxin‐Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway
por: Chen, Wei‐Ju, et al.
Publicado: (2022)

Podocalyxin regulates pronephric glomerular development in zebrafish
por: Ichimura, Koichiro, et al.
Publicado: (2013)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
por: Khaddour, Karam, et al.
Publicado: (2020)

Determination of critical epitope of PcMab-47 against human podocalyxin
por: Itai, Shunsuke, et al.
Publicado: (2018)

Podocalyxin in Normal Tissue and Epithelial Cancer
por: Le Tran, Ngoc, et al.
Publicado: (2021)

Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
por: Sarica, Feyzi Birol, et al.
Publicado: (2012)

Clinicopathological characteristics and survival of spinal cord astrocytomas
por: Zhang, Yao‐Wu, et al.
Publicado: (2020)

Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)
por: Fang, Jingai, et al.
Publicado: (2013)

The cell surface mucin podocalyxin regulates collective breast tumor budding
por: Graves, Marcia L., et al.
Publicado: (2016)

Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function
por: Román-Fernández, Alvaro, et al.
Publicado: (2023)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
por: Liu, Yu, et al.
Publicado: (2014)

Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma
por: Flores-Téllez, Teresita N. J., et al.
Publicado: (2015)

Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
por: Novo, David, et al.
Publicado: (2018)

Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2017)

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
por: Hara, M., et al.
Publicado: (2012)

PINCH1 Is Transcriptional Regulator in Podocytes That Interacts with WT1 and Represses Podocalyxin Expression
por: Wang, Dan, et al.
Publicado: (2011)

Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer
por: Lee, Wen-Ying, et al.
Publicado: (2017)

Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion
por: Debruin, Erin J., et al.
Publicado: (2014)

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
por: Paravati, Anthony J., et al.
Publicado: (2010)

Correction: Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
Publicado: (2015)

Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models
por: Canals Hernaez, Diana, et al.
Publicado: (2022)

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
por: Yang, Zhuanyi, et al.
Publicado: (2010)

Correction: Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion
Publicado: (2014)

Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
por: Taniuchi, Keisuke, et al.
Publicado: (2016)

Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
por: Hirano, Hirofumi, et al.
Publicado: (2017)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
por: Feldheim, Jonas, et al.
Publicado: (2022)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Podocalyxin promotes an impermeable epithelium and inhibits pro-implantation factors to negatively regulate endometrial receptivity
por: Heng, Sophea, et al.
Publicado: (2021)

Inhibition of STAT3 Reduces Astrocytoma Cell Invasion and Constitutive Activation of STAT3 Predicts Poor Prognosis in Human Astrocytoma
por: Liang, Qinchuan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5qj0tac7v5m0per7iqlffieacr